CAS 1417158-65-6

Xentuzumab

CAS : 1417158-65-6

Xentuzumab (BI836845) is a recombinant monoclonal antibody to humanised IGF ligand that inhibits AKT activation and can be used to study solid tumours.

Degré de pureté : 95.21% - >95.0% (SDS-PAGE); >95.0% (SEC-HPLC)

Couleur et forme : Liquid

Masse moléculaire : 143.7 kDa

Ref: TM-T76795

Xentuzumab

CAS : 1417158-65-6

Humanized IgG1 insulin-like growth factor (IGF) monoclonal antibody targeting the IGF ligands 1 (IGF-1) and 2 (IGF-2)

Ref: 3D-CLA1415